AI assistant
Nanobiotix — Declaration of Voting Results & Voting Rights Announcements 2026
Apr 7, 2026
1541_dva_2026-04-07_6a980167-c444-4a37-b06b-eb8928c9d9ad.pdf
Declaration of Voting Results & Voting Rights Announcements
Open in viewerOpens in your device viewer
NANOBIOTIX
EXPANDING
LIFE
PRESS RELEASE
VOTING RIGHTS AND SHARES CAPITAL OF THE COMPANY
In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)
Paris, France, April 7, 2026
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website: www.nanobiotix.com
| Date | Number of Shares Outstanding | Total number of voting rights | |
|---|---|---|---|
| Total voting rights, theoretical1 | Total voting rights, exercisable2 | ||
| March 31, 2026 | 48,517,630 | 50,165,132 | 50,143,014 |
About NANOBIOTIX
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people committed to making a difference for humanity. The Company's philosophy is rooted in the concept of pushing past the boundaries of what is known to expand possibilities for human life.
Incorporated in 2003, Nanobiotix is headquartered in Paris, France and is listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has a subsidiary in Cambridge, Massachusetts (United States).
Nanobiotix is the owner of more than 30 patent families associated with three (3) nanotechnology platforms with applications in 1) oncology; 2) bioavailability and biodistribution; and 3) disorders of the central nervous system.
For more information about Nanobiotix, visit us at www.nanobiotix.com or follow us on LinkedIn and Twitter.
NANOBIOTIX
EXPANDING
LIFE
Contacts
Nanobiotix
| Communications Department | Investor Relations Department |
|---|---|
| Brandon Owens | Joanne Choi |
| VP, Communications | VP, Investor Relations (US) |
| +1 (617) 852-4835 | +1 (713) 609-3150 |
| [email protected] | Ricky Bhajun |
| Director, Investor Relations (EU) | |
| [email protected] |
Media Relations
| France – HARDY | Global – uncapped |
|---|---|
| Caroline Hardy | Becky Lauer |
| +33 06 70 33 49 50 | +1 (646) 286-0057 |
| [email protected] | [email protected] |
NBTX
Nasdaq Listed
NANO
LISTED
EURONEXT